Factors associated with fatal outcome in 48 MERS cases.

<p>Factors associated with fatal outcome in 48 MERS cases.</p

Time from hospital admission to death.

<p>A: Comparing patients with MERS-CoV infection (red line) and those negative for MERS-CoV (black line) (p = 0.01). B: Comparing health care workers with MERS CoV (red dotted line; group1), non-HCW with MERS (red solid line; group 2) and patients without MERS-CoV infection (black solid line; group 3). Log rank test group 1 vs. group 2 p = 0.003; group 2 vs group 3 p = 0.45; group 1 vs group 3 p<0.001.</p

Factors associated with poor outcome (admission to ICU or death) among 48 MERS patients.

<p>Factors associated with poor outcome (admission to ICU or death) among 48 MERS patients.</p

Factors associated with fatal outcome in 48 MERS cases.

<p>Factors associated with fatal outcome in 48 MERS cases.</p

Comparison of laboratory parameters among three patient groups.

<p>Comparison of laboratory parameters among three patient groups.</p

Comparison of clinical symptoms and co-morbidity status among the three patient groups.

<p>Comparison of clinical symptoms and co-morbidity status among the three patient groups.</p

Demographics of MERS positive HCW, MERS positive non-HCW and MERS negative cases.

<p>Demographics of MERS positive HCW, MERS positive non-HCW and MERS negative cases.</p

Time from hospital admission to death stratified by comorbid disease status among MERS positive cases.

<p>Survival analysis was carried out to ascertain impact of co-morbidities on survival in patients with MERS-CoV infection. Black line (group 1): No comorbid disease; Red line (group 2): Diabetes with or without other comorbidities; Green line (group 3): Any other comorbid disease without diabetes. Log rank test: group 1 vs group 2 p = 0.01; Group 1 vs. group 3 p = 0.54; group 2 vs. group 3 p = 0.01.</p